Compulsive buying disorder clustering based on sex, age, onset and personality traits

详细信息    查看全文

• 作者：Roser Granero^a ; ^b ; Fernando Ferná ; ndez-Aranda^a ; ^c ; ^d ; Marta Bañ ; o^a ; ^c ; Trevor Steward^a ; ^c ; Gemma Mestre-Bach^c ; Amparo del Pino-Guti&eacute ; rrez^e ; Laura Moragas^c ; Nú ; ria Mallorquí ; -Bagu&eacute ; ^a ; ^c ; Neus Aymamí ; ^c ; Mó ; nica Gom&eacute ; z-Peñ ; a^c ; Salom&eacute ; Tá ; rrega^b ; Jos&eacute ; M. Menchó ; n^c ; ^d ; ^f ; Susana Jim&eacute ; nez-Murcia^a ; ^c ; ^d ; ^{sjimenez@bellvitgehospital.cat" class="auth_mail" title="E-mail the corresponding author}
• 刊名：Comprehensive Psychiatry
• 出版年：2016
• 出版时间：July 2016
• 年：2016
• 卷：68
• 期：Complete
• 页码：1-10
• 全文大小：697 K

文摘

In spite of the revived interest in compulsive buying disorder (CBD), its classification into the contemporary nosologic systems continues to be debated, and scarce studies have addressed heterogeneity in the clinical phenotype through methodologies based on a person-centered approach.

Objectives

To identify empirical clusters of CBD employing personality traits, as well as patients' sex, age and the age of CBD onset as indicators.

Methods

An agglomerative hierarchical clustering method defining a combination of the Schwarz Bayesian Information Criterion and log-likelihood was used.

Results

Three clusters were identified in a sample of n = 110 patients attending a specialized CBD unit a) “male compulsive buyers” reported the highest prevalence of comorbid gambling disorder and the lowest levels of reward dependence; b) “female low-dysfunctional” mainly included employed women, with the highest level of education, the oldest age of onset, the lowest scores in harm avoidance and the highest levels of persistence, self-directedness and cooperativeness; and c) “female highly-dysfunctional” with the youngest age of onset, the highest levels of comorbid psychopathology and harm avoidance, and the lowest score in self-directedness.

Conclusion

Sociodemographic characteristics and personality traits can be used to determine CBD clusters which represent different clinical subtypes. These subtypes should be considered when developing assessment instruments, preventive programs and treatment interventions.